Use of Branched Chain Amino Acid (BCAA) Supplements for Chronic Stroke Patients

Recruiting

Phase N/A Results N/A

Trial Description

In the past few years, Branched Chain Amino Acid (BCAA) supplements have gradually used on different groups. From training athletes, maintaining functions of healthy elders to preventing disabilities of people that can't do intense exercises. BCAAs are now considered to be able to prevent muscle atrophy and strength loss, also possible to increase strength and muscle mass if combined with resistance exercises. Stroke patients have difficulties with moving, which led to multiple disabilities, are more likely to have sarcopenia and strength loss. Furthermore, reducing the will of moving or walking. Recently, studies showed that combined BCAAs with resistance exercises can effectively increase muscle mass, thus commonly used on training athletes.
Although aerobic exercises are proven to be more likely to improve walking ability of chronic stroke patients than traditional rehabilitation, BCAAs' effects are yet to be proven. Therefore, the aim of this study is to explore if BCAAs combined with moderate intensity exercises can prevent muscle atrophy, loss of strength and cardiopulmonary function.
This is a randomized control trial. Participants are randomly assigned to either experiment or control groups. Both group received aerobic exercise (30 min in a session, 3 days a week, and for 8 weeks). Experiment group received BCAA supplement immediately after the exercise while the control group receive sham product (vitamins). The outcome measurements (including muscle mass, functional measures, and quality of life) are performed before (0-wk) and after (8-wk) the interventions.

Detailed Description

Setting : inpatient rehabilitation department of Wan-Fang Hospital. Study population : Patients received inpatient treatment or rehabilitation for stroke in Wan-Fang Hospital (WFH).
Study design: controlled trial with randomization Blinding : The patients were blinded by the real or sham bcaa supplements. The assessors who performed the outcome measurements were blinded to the assignment of treatment.
Measurements : DXA(Dual-energy X-ray absorptiometry),CPET(Cardiopulmonary Exercise Testing),6 minute walk test,Timed up and go,Berg balance test,Stroke Specific Quality of Life Scale (SS-QOL).
These measurements (including the clinical and corticomotor excitability assessments) are performed by one researcher who are responsible for the measurements.
Compliance and side effect. The compliance of supplements were investigated. The attendance of treatments (including bcaa supplements and physical therapy sessions) and possible side effect/discomfort were recorded during the interventions by a researcher. He also tries to understand the reason of drop-out from the study.

Conditions

Interventions

  • Aerobic Exercise Other
    Intervention Desc: The exercise intervention includes 24 aerobic stationary cycling sessions (30 min/session, 3 session/week, and 8 weeks). The exercise sessions proceed under the supervision and guidance of a therapist.
    ARM 1: Kind: Experimental
    Label: BCAA group
    Description: Participants in the BCAA group take 40g of BCAA supplement before each aerobic exercise session. The interventions include 24 aerobic training sessions. Accordingly, the participants intake 960g of BCAA during a 8-week intervention period.
    ARM 2: Kind: Experimental
    Label: Control group
    Description: Participants in the control group take 40g of placebo before each aerobic training session. The placebo has the same caloric as the BCAA supplement but with different constitution (eg, different percentage of protein, fat and carbohydrate)
  • BCAA supplement Dietary Supplement
    Intervention Desc: Before each exercise session (described later), the research assistant will give subjects 40g of BCAA or placebo supplement according to the treatment assignment and ask them to drink it down right away.
    ARM 1: Kind: Experimental
    Label: BCAA group
    Description: Experimental group included aerobic exercise (30 minutes in a session, 3 days a week for 8 weeks) and receives BCAA supplement immediately after the exercise.
    ARM 2: Kind: Experimental
    Label: Placebo product
    Description: Placebo comparator group included aerobic exercise (30 minutes in a session, 3 days a week for 8 weeks) and receives sham product immediately after the exercise.
    ARM 3: Kind: Experimental
    Label: Control group
    Description: Participants in the control group take 40g of placebo before each aerobic training session. The placebo has the same caloric as the BCAA supplement but with different constitution (eg, different percentage of protein, fat and carbohydrate)

Outcomes

Type Measure Time Frame Safety Issue
Primary DXA 8 weeks after intervention
Primary Body fat scale 8 weeks after intervention
Secondary Timed up and go (TUG) 8 weeks after intervention
Secondary Burg Balance Test 8 weeks after intervention
Secondary CPET 8 weeks after intervention
Secondary Stroke Specific Quality of Life Scale(SS-QOL) 8 weeks after intervention
Secondary 6 minutes walk test 8 weeks after intervention

Sponsors